Shanghai MicroPort MedBot (Group) Co., Ltd. (SEHK: 2252)
Health Care · Health Care Equipment & Supplies · CN
HK$—
— today · — 1Y
Shanghai MicroPort MedBot (Group) Co., Ltd. (SEHK: 2252) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $2.79B and employs 464 people.
trading between 19.64 and 35.34.
Tweenvest scores Shanghai MicroPort MedBot (Group) Co., Ltd. across four factors: quality 35/100, value 63/100. Its strongest factor is value.
2252 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.79B
- Revenue (TTM)
- $78.79M
- P/E
- —
- EPS
- -0.24
- Dividend yield
- —
- Beta (5Y)
- 1.45
- 52-week high
- HK$35.34
- 52-week low
- HK$19.64
- Avg volume (3M)
- —
- Shares outstanding
- 1.03B
- Employees
- 464
- Next earnings
- —
About Shanghai MicroPort MedBot (Group) Co., Ltd.
Shanghai MicroPort MedBot (Group) Co., Ltd. focuses on the comprehensive research, development, design, production, and distribution of surgical robotic systems, catering to markets in China and Europe. Their innovative product range features Toumai, a versatile laparoscopic surgical robot employed in urologic, gynecologic, thoracic, and general surgeries. They also provide DFVision, a 3D electronic laparoscope designed to improve visualization during abdominal, thoracic, and pelvic operations. For orthopedic procedures, the Honghu robot aids in knee and hip joint replacements, while the R-One system is specifically engineered for vascular interventions like coronary angioplasty. The iSR'obot, known as the Mona Lisa robotic system, specializes in transperineal prostate biopsies. Additionally, the company's offerings extend to specialized robots for spinal procedures, trans-bronchial diagnosis and treatment, TAVR (Transcatheter Aortic Valve Replacement), and automated needle-targeting systems for precise percutaneous lung biopsies and nephrolithotomy. Founded in 2014 and headquartered in Shanghai, China, the company functions as a subsidiary of MicroPort Scientific Corporation.
- ISIN
- CNE100004QP1
- Founded
- 2014
- Listed since
- Nov 2, 2021
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hangzhou Diagens Biotechnology Co., Ltd.SEHK: 2526 | $3.04B | HK$268.60 | -8.08% |
| Autobio Diagnostics Co., Ltd.SHSE: 603658 | $2.85B | CN¥33.45 | -1.85% |
| Ambu A/SCPSE: AMBU B | $2.85B | Dkr75.10 | +3.09% |
| AtriCure, Inc.NasdaqGM: ATRC | $2.84B | $56.14 | +0.59% |
| Medacta Group SASWX: MOVE | $2.74B | CHF114.20 | 0.00% |
| TransMedics Group, Inc.NasdaqGM: TMDX | $2.70B | $77.74 | -0.17% |
| Winner Medical Co., Ltd.SZSE: 300888 | $2.69B | CN¥31.36 | +5.06% |
| Neogen CorporationNasdaqGS: NEOG | $2.59B | $12.01 | +1.31% |
Figures last refreshed Oct 11, 2026.